The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
Open accessAbstract
BACKGROUND: Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated with nonvaccine oncogenic HPV types was evaluated. METHODS: We enrolled 17,622 women aged 16-26 years. All underwent cervicovaginal sampling and Pap testing at regular intervals for up to 4 years. HPV genotyping was performed for biopsy samples, and histological diagnoses were determined by a pathology panel. Analyses were conducted among subjects who were negative for 14 HPV types on day 1. Prespecified analyses included infection of 6 months' duration and CIN1-3/AIS due to the 2 and 5 most common HPV types in cervical cancer after HPV types 16 and 18, as well as all tested nonvaccine types. RESULTS: Vaccination reduced the incidence of HPV-31/45 infection by 40.3% (95% confidence interval [CI], 13.9% to 59.0%) and of CIN1-3/AIS by 43.6% (95% CI, 12.9% to 64.1%), respectively. The reduction in HPV-31/33/45/52/58 infection and CIN1-3/AIS was 25.0% (95% CI, 5.0% to 40.9%) and 29.2% (95% CI, 8.3% to 45.5%), respectively. Efficacy for CIN2-3/AIS associated with the 10 nonvaccine HPV types was 32.5% (95% CI, 6.0% to 51.9%). Reductions were most notable for HPV-31. CONCLUSIONS: HPV-6/11/16/18 vaccine reduced the risk of CIN2-3/AIS associated with nonvaccine types responsible for approximately 20% of cervical cancers. The clinical benefit of cross-protection is not expected to be fully additive to the efficacy already observed against HPV-6/11/16/18-related disease, because women may have >1 CIN lesion, each associated with a different HPV type. TRIAL REGISTRATION: ClinicalTrials.gov identifiers: NCT00092521 , NCT00092534 , and NCT00092482.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Self-citationClassification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Self-citationSmith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22527 · Cited by 1,686
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Self-citationChapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Self-citationClifford, G. M., Smith, J. S., Aguado, T., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601024 · Cited by 684
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Self-citationA 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Self-citationHuman papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Penny, M. E., Aranda, C., Vardas, E., Moi, H., Jessen, H., Hillman, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0909537 · Cited by 1,146
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Self-citationA review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Self-citationDrolet, M., Bénard, É., Boily, M.-C., Ali, H., Baandrup, L., Bauer, H., Beddows, S., Brisson, J., Brotherton, J. M. L., Cummings, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71073-4 · Cited by 642
Self-citationArbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009069.pub3 · Cited by 621
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
Self-citationMarkowitz, L. E., Hariri, S., Lin, C., Dunne, E. F., Steinau, M., McQuillan, G., & Unger, E. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit192 · Cited by 521
Wheeler, C. M., Castellsagué, X., Garland, S. M., Szarewski, A., Paavonen, J., Naud, P., Salmerón, J., Chow, S.-N., Apter, D., Kitchener, H., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70287-x · Cited by 507
Self-citationMalagón, T., Drolet, M., Boily, M.-C., Franco, E. L., Jit, M., Brisson, J., & Brisson, M. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70187-1 · Cited by 429
Prevalence of HPV After Introduction of the Vaccination Program in the United States
Markowitz, L. E., Liu, G., Hariri, S., Steinau, M., Dunne, E. F., & Unger, E. R. (2016) · Pediatrics · doi:10.1542/peds.2015-1968 · Cited by 383
Hariri, S., Unger, E. R., Sternberg, M., Dunne, E. F., Swan, D., Patel, S., & Markowitz, L. E. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir341 · Cited by 380
Chaturvedi, A. K., Katki, H. A., Hildesheim, A., Rodríguez, A. C., Quint, W., Schiffman, M., Van Doorn, L.-J., Porras, C., Wacholder, S., Gonzalez, P., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq139 · Cited by 329
Joura, E. A., Garland, S. M., Paavonen, J., Ferris, D. G., Perez, G., Ault, K. A., Huh, W. K., Sings, H. L., James, M. K., Haupt, R. M., et al. (2012) · BMJ · doi:10.1136/bmj.e1401 · Cited by 316
Self-citationTabrizi, S. N., Brotherton, J. M. L., Kaldor, J. M., Skinner, S. R., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Phillips, S., Cummins, E., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70841-2 · Cited by 301
Self-citationUnderstanding and learning from the success of prophylactic human papillomavirus vaccines
Schiller, J. T., & Lowy, D. R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2872 · Cited by 293
Lu, B., Kumar, A., Castellsagué, X., & Giuliano, A. R. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-13 · Cited by 283
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
Human papillomavirus molecular biology
Harden, M. E., & Munger, K. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.07.002 · Cited by 260
Van de Velde, N., Boily, M.-C., Drolet, M., Franco, E. L., Mayrand, M.-H., Kliewer, E. V., Coutlée, F., Laprise, J.-F., Malagón, T., & Brisson, M. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs395 · Cited by 140
Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV Types
Herrero, R. (2009) · The Journal of Infectious Diseases · doi:10.1086/597308 · Cited by 104
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Integrating clinical, community, and policy perspectives on human papillomavirus vaccination
Fernández, M. E., Allen, J. D., Mistry, R., & Kahn, J. A. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103609 · Cited by 97
Paz-Zulueta, M., Álvarez-Paredes, L., Rodríguez Díaz, J. C., Parás-Bravo, P., Andrada Becerra, M. E., Rodríguez Ingelmo, J. M., Ruiz García, M. M., Portilla, J., & Santibañez, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4033-2 · Cited by 58
Brisson, M., Laprise, J.-F., Drolet, M., Van de Velde, N., Franco, E. L., Kliewer, E. V., Ogilvie, G., Deeks, S. L., & Boily, M.-C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.064 · Cited by 56
Age-specific occurrence of HPV16- and HPV18-related cervical cancer
de Sanjose, S., Wheeler, C. M., Quint, W. G. V., Hunt, W. C., Joste, N. E., Alemany, L., Xavier Bosch, F., Myers, E. R., & Castle, P. E. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0053 · Cited by 51
Self-citationYoshikawa, H., Ebihara, K., Tanaka, Y., & Noda, K. (2013) · Cancer Science · doi:10.1111/cas.12106 · Cited by 46
Estrade, C., Menoud, P.-A., Nardelli-Haefliger, D., & Sahli, R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05039-11 · Cited by 40
Human Papillomavirus Genotype Distribution in Invasive Cervical Cancer in Pakistan
Loya, A., Serrano, B., Rasheed, F., Tous, S., Hassan, M., Clavero, O., Raza, M., De Sanjosé, S., Bosch, F., & Alemany, L. (2016) · Cancers · doi:10.3390/cancers8080072 · Cited by 27
Self-citation
Metadata
- Authors
- Brown, D. R., Kjaer, S. K., Sigurdsson, K., Iversen, O., Hernandez‐Avila, M., Wheeler, C. M., Perez, G., Koutsky, L. A., Tay, E. H., Garcia, P., Ault, K. A., Garland, S. M., Leodolter, S., Olsson, S., Tang, G. W. K., Ferris, D. G., Paavonen, J., Steben, M., Bosch, F. X., Dillner, J., Joura, E. A., Kurman, R. J., Majewski, S., Muñoz, N., Myers, E. R., Villa, L. L., Taddeo, F. J., Roberts, C., Tadesse, A., Bryan, J., Lupinacci, L. C., Giacoletti, K. E. D., Sings, H. L., James, M., Hesley, T. M., & Barr, E.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04
- Volume
- 199
- Issue
- 7
- Pages
- 926-935
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2123962939
- Cited by
- 627
- References
- 44
- FWCI
- 50.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.